Over the past decades, b-type natriuretic peptide (BNP) and its derivative N-terminal fragment (NT-proBNP) have been reported as cardiovascular biomarkers, mainly for heart failure (HF) diagnosis as well as for stroke monitoring [125,126]. This evidence concerns the gene NPPB and hydrops fetalis.